' '
Deutsch | English    

Research Database PMU-SQQUID

WEISS LUKAS
Department of Internal Medicine I - Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetology
Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Publications

103 Publications

2023

Journal Articles

Prognostic value of [
Mirshahvalad, SA; Seyedinia, SS; Huemer, F; Schweighofer-Zwink, G; Koch, O; Hitzl, W; Weiss, L; Emannuel, K; Greil, R; Pirich, C; Beheshti, M;
Eur J Radiol. 2023; 163:110843
Full papers/articles (Journal)
Abstract/Keywords PubMed Full Text
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer.
Wagner, SM; Magnes, T; Melchardt, T; Kiem, D; Weiss, L; Neureiter, D; Wagner, C; Aretin, MB; Nemec, S; Gamerith, G; Pall, G; Greil, R; Fuereder, T;
Anticancer Res. 2023; 43(3):1273-1282
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

2022

Journal Articles

The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
Folprecht, G; Reinacher-Schick, A; Weitz, J; Lugnier, C; Kraeft, AL; Wisser, S; Aust, DE; Weiss, L; von Bubnoff, N; Kramer, M; Thiede, C; Tannapfel, A
CLIN COLORECTAL CANC. 2022; 21(2): 170-174.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
Huemer, F; Hecht, S; Scharinger, B; Schlintl, V; Rinnerthaler, G; Schlick, K; Heregger, R; Melchardt, T; Wimmer, A; Mühlbacher, I; Koch, OO; Neureiter, D; Klieser, E; Seyedinia, S; Beheshti, M; Greil, R; Weiss, L;
J Cancer Res Clin Oncol. 2022;
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant Therapy.
Roeder, F; Gerum, S; Hecht, S; Huemer, F; Jäger, T; Kaufmann, R; Klieser, E; Koch, OO; Neureiter, D; Emmanuel, K; Sedlmayer, F; Greil, R; Weiss, L;
Cancers (Basel). 2022; 14(22):
Reviews
Abstract/Keywords Web of Science PubMed Full Text
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
Schlintl, V; Huemer, F; Rinnerthaler, G; Melchardt, T; Winder, T; Reimann, P; Riedl, J; Amann, A; Eisterer, W; Romeder, F; Piringer, G; Ilhan-Mutlu, A; Wöll, E; Greil, R; Weiss, L;
BMC Cancer. 2022; 22(1): 51
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
ESMO 2021-highlights in colorectal cancer.
Weiss, L
MEMO-MAG EUR MED ONC. 2022; 15(2): 114-116.
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Conference papers, proceedings, abstracts

The influence of pancreatic regression characteristics on outcome of neoadjuvant treated pancreatic cancer in two Austrian university centres
Neumayer, B; Neureiter, D; Klieser, E; Huemer, F; Weiss, L; Greil, R; Djanani, A; Oberhuber, G; Schlick, K
Virchows Archiv. 2022; 481(Supplement 1):S135-S135.-34th European Congress of Pathology; 03.-07.09.2022; Basel.
Full papers/articles (Journal)
Abstract/Keywords

2021

Journal Articles

Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature.
Heregger, R; Huemer, F; Hutarew, G; Hecht, S; Cheveresan, L; Kotzot, D; Schamschula, E; Rinnerthaler, G; Melchardt, T; Weiss, L; Greil, R;
ESMO Open. 2021; 6(4):100233
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Magnes, T; Wagner, S; Kiem, D; Weiss, L; Rinnerthaler, G; Greil, R; Melchardt, T;
Int J Mol Sci. 2021; 22(9):
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.
Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Schlick, K; Zaborsky, N; Steiner, M; Greil, R; Egle, A; Melchardt, T;
Cancers (Basel). 2021; 13(4):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence.
Magnes, T; Wagner, S; Thorner, AR; Neureiter, D; Klieser, E; Rinnerthaler, G; Weiss, L; Huemer, F; Zaborsky, N; Steiner, M; Weis, S; Greil, R; Egle, A; Melchardt, T;
ESMO Open. 2021; 6(1): 100012
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R;
Wien Klin Wochenschr. 2021; 133(21-22):-1136.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients.
Schlick, K; Kiem, D; Huemer, F; Neureiter, D; Weiss, L; Greil, R;
Technol Cancer Res Treat. 2021; 20: 15330338211042139
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick, K; Markus, S; Huemer, F; Ratzinger, L; Zaborsky, N; Clemens, H; Neureiter, D; Neumayer, B; Beate, AS; Florian, S; Martin, V; Grundbichler, M; Weiss, L; Melchardt, T; Greil, R; Egle, A;
Pancreatology. 2021; 21(8):1466-1471
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
Schlintl, V; Huemer, F; Greil, R; Weiss, L;
J Gastrointest Oncol. 2021; 12(2): 906-909.
Letters
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T
Wien Klin Wochenschr. 2021; 133(1-2):21-25
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
ASCO 2021-an update on metastastic colorectal cancer
Weiss, L
MEMO-MAG EUR MED ONC. 2021;
Reviews
Abstract/Keywords Web of Science Full Text

2020

Journal Articles

Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Huemer, F; Klieser, E; Neureiter, D; Schlintl, V; Rinnerthaler, G; Pagès, F; Kirilovsky, A; El Sissy, C; Iglseder, W; Singhartinger, F; Jäger, T; Dinnewitzer, A; Zaborsky, N; Steiner, M; Greil, R; Weiss, L;
J Clin Med. 2020; 9(9):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L;
Cancers (Basel). 2020; 12(10):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
Huemer, F; Weiss, L; Regitnig, P; Winder, T; Hartmann, B; Thaler, J; Piringer, G; Schmitt, CA; Eisterer, W; Gänzer, H; Wüstner, A; Andel, J; Jagdt, B; Ulmer, H; Greil, R; Wöll, E;
J Clin Med. 2020; 9(4):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.
Hufnagl, C; Leisch, M; Weiss, L; Melchardt, T; Moik, M; Asslaber, D; Roland, G; Steininger, P; Meissnitzer, T; Neureiter, D; Greil, R; Egle, A;
Oncol Lett. 2020; 19(2):-1558.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;
Pharmacogenomics J. 2020; 20(2):350
Corrections
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Safe application of extensive radiotherapy to a cardiac resynchronization device.
Schernthaner, C; Kopp, M; Dagn, K; Rettenbacher, L; Weiss, L; Meyersburg, D; Brandt, MC; Hoppe, UC; Strohmer, B;
ESC Heart Fail. 2020; 7(6):4293-4296
Case Reports
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz, C; Romagna, A; Stefanits, H; Zimmermann, G; Ladisich, B; Geiger, P; Rechberger, J; Winkler, S; Weiss, L; Fastner, G; Trinka, E; Weis, S; Spiegl-Kreinecker, S; Steinbacher, J; McCoy, M; Johannes, T; Gruber, A; Jahromi, BR; Niemelä, M; Winkler, PA; Thon, N;
World Neurosurg. 2020; 133:e583-e591
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217
Folprecht, G; Reinacher-Schick, A; Tannapfel, A; Weitz, J; Kossler, T; Weiss, L; Aust, DE; von Bubnoff, N; Kramer, M; Thiede, C
J CLIN ONCOL. 2020; 38(4):
Abstracts (Journal)
Abstract/Keywords Web of Science
Hospitalizations and clinical outcome in metastatic colorectal cancer during regorafenib or TAS-102 therapy
Huemer, F; Piringer, G; Schlintl, V; Hackl, H; Rinnerthaler, G; Thaler, J; Greil, R; Weiss, L
ONCOL RES TREAT. 2020; 43(SUPPL 4): 128-128.
Abstracts (Journal)
Abstract/Keywords Web of Science

2019

Journal Articles

Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals.
Bolger, GT; Licollari, A; Tan, A; Greil, R; Vcelar, B; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Majeed, M; Sordillo, PP;
Cancer Chemother Pharmacol. 2019; 83(2):265-275
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A; Melchardt, T; Obrtlíková, P; Smolej, L; Kozák, T; Steurer, M; Andel, J; Burgstaller, S; Mikušková, E; Gercheva, L; Nösslinger, T; Papajík, T; Ladická, M; Girschikofsky, M; Hrubiško, M; Jäger, U; Voskova, D; Pecherstorfer, M; Králiková, E; Burcoveanu, C; Spasov, E; Petzer, A; Mihaylov, G; Raynov, J; Oexle, H; Zabernigg, A; Flochová, E; Palášthy, S; Stehlíková, O; Doubek, M; Altenhofer, P; Weiss, L; Magnes, T; Pleyer, L; Klingler, A; Mayer, J; Greil, R;
Cancer Med. 2019; 8(4):-1405.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.
Huemer, F; Lang, D; Westphal, T; Gampenrieder, SP; Hutarew, G; Weiss, L; Hackl, H; Lamprecht, B; Rinnerthaler, G; Greil, R;
J Clin Med. 2019; 8(7):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.
Huemer, F; Schlintl, V; Hecht, S; Hackl, H; Melchardt, T; Rinnerthaler, G; Greil, R; Weiss, L;
Clin Colorectal Cancer. 2019; 18(2):159-166.e3
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A;
J Clin Med. 2019; 8(11):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Woll, E; Eisterer, W; Gerger, A; Kuhr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R
ANTICANCER RES. 2019; 39(9): 4589-4596.
Reviews
Abstract/Keywords Web of Science PubMed Full Text

2018

Journal Articles

Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;
Ann Hematol. 2018; 97(9):1745
Corrections
Abstract/Keywords Web of Science PubMed Full Text
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A; Steurer, M; Melchardt, T; Weiss, L; Gassner, FJ; Zaborsky, N; Geisberger, R; Catakovic, K; Hartmann, TN; Pleyer, L; Voskova, D; Thaler, J; Lang, A; Girschikofsky, M; Petzer, A; Greil, R;
Ann Hematol. 2018; 97(10): 1825-1839.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc
Greil, R; Greil-Ressler, S; Weiss, L; Schönlieb, C; Magnes, T; Radl, B; Bolger, GT; Vcelar, B; Sordillo, PP;
Cancer Chemother Pharmacol. 2018; 82(4): 695-706.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer, F; Rinnerthaler, G; Westphal, T; Hackl, H; Hutarew, G; Gampenrieder, SP; Weiss, L; Greil, R;
Oncotarget. 2018; 9(23):-16520
Full papers/articles (Journal)
Abstract/Keywords PubMed PUBMED Central Full Text
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F; Thaler, J; Piringer, G; Hackl, H; Pleyer, L; Hufnagl, C; Weiss, L; Greil, R;
BMC Cancer. 2018; 18(1): 11
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.
Huemer, F; Weiss, L; Faber, V; Neureiter, D; Egle, A; Geissler, K; Voskova, D; Zebisch, A; Burgstaller, S; Pichler, A; Stauder, R; Sperr, W; Lang, A; Pfeilstöcker, M; Machherndl-Spandl, S; Stampfl, M; Greil, R; Pleyer, L;
Wien Klin Wochenschr. 2018; 130(3-4): 115-125.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T; Melchardt, T; Hufnagl, C; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Rinnerthaler, G; Roesch, S; Gaggl, A; Greil, R; Egle, A;
Pharmacogenomics J. 2018; 18(3):-479
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt, T; Magnes, T; Hufnagl, C; Thorner, AR; Ducar, M; Neureiter, D; Tränkenschuh, W; Klieser, E; Gaggl, A; Rösch, S; Rasp, G; Hartmann, TN; Pleyer, L; Rinnerthaler, G; Weiss, L; Greil, R; Egle, A;
Eur J Cancer. 2018; 93:69-78
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K; Magnes, T; Ratzinger, L; Jaud, B; Weiss, L; Melchardt, T; Greil, R; Egle, A;
PLoS One. 2018; 13(11): e0206688
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.
Schwartz, C; Romagna, A; Machegger, L; Weiss, L; Huemer, F; Fastner, G; Kleindienst, W; Serge, W; Greil, R; Winkler, PA;
World Neurosurg. 2018; 120:442-447
Case Reports
Abstract/Keywords Web of Science PubMed Full Text

2017

Journal Articles

Intermittent low-dose bevacizumab in hereditary hemorrhagic telangiectasia : A case report.
Huemer, F; Dejaco, M; Grabmer, C; Melchardt, T; Neureiter, D; Mayer, G; Egle, A; Greil, R; Weiss, L;
Wien Klin Wochenschr. 2017; 129(3-4):-144
Case Reports
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M; Weiss, L; Lindlbauer, N; Jungbauer, C; Egle, A; Rohde, E; Greil, R; Grabmer, C; Pleyer, L;
Leuk Res. 2017; 59:12-19
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A;
PLoS One. 2017; 12(7):e0180995
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
ASCO-update: gastrointestinal tumors.
Weiss, L; Huemer, F; Greil, R;
Memo. 2017; 10(4): 240-243.
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Hackl, H; Greil, R; Barth, J; Rummel, M;
Ann Hematol. 2017; 96(7): 1155-1162.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E; Thaler, J; Keil, F; Gruenberger, B; Hejna, M; Eisterer, W; Fridrik, MA; Ulmer, H; Trommet, V; Huemer, F; Weiss, L; Greil, R;
Anticancer Res. 2017; 37(10): 5553-5558.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

2016

Journal Articles

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.
Magnes, T; Melchardt, T; Weiss, L; Hufnagl, C; Greil, R; Egle, A;
J Clin Oncol. 2016; 34(20):2433-2434
Letters
Abstract/Keywords Web of Science PubMed Full Text
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Melchardt, T; Hufnagl, C; Weinstock, DM; Kopp, N; Neureiter, D; Tränkenschuh, W; Hackl, H; Weiss, L; Rinnerthaler, G; Hartmann, TN; Greil, R; Weigert, O; Egle, A;
Oncotarget. 2016; 7(32):51494-51502
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M;
Br J Cancer. 2016; 115(10):1264-1272
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M;
J Clin Pathol. 2016; 69(4):326-330
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Immune checkpoint blockade in ovarian cancer.
Weiss, L; Huemer, F; Mlineritsch, B; Greil, R;
Memo. 2016; 9:82-84
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

2015

Journal Articles

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.
Huemer, F; Melchardt, T; Tränkenschuh, W; Neureiter, D; Moser, G; Magnes, T; Weiss, L; Schlattau, A; Hufnagl, C; Ricken, G; Höftberger, R; Greil, R; Egle, A;
BMC Cancer. 2015; 15:996
Case Reports
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer.
Melchardt, T; Hufnagl, C; Magnes, T; Weiss, L; Hutarew, G; Neureiter, D; Schlattau, A; Moser, G; Gaggl, A; Tränkenschuh, W; Greil, R; Egle, A;
BMC Cancer. 2015; 15:725
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A;
Br J Haematol. 2015; 168(2):239-245
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A;
J Natl Compr Canc Netw. 2015; 13(12):1501-1508
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Morre, P; Boekstegers, A; Hopfinger, G; Auberger, J; Steinkirchner, S; Pleyer, L; Greil, R; Egle, A;
Leuk Lymphoma. 2015; 56(2):353-360
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M;
Eur J Haematol. 2015; 95(6):538-544
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

Immunotherapy of ovarian cancer
Weiss, L; Mlineritsch, B; Greil, R
ONCOL RES TREAT. 2015; 38: 6-6.
Abstracts (Journal)
Abstract/Keywords Web of Science

2014

Journal Articles

Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Grössinger, EM; Weiss, L; Zierler, S; Rebhandl, S; Krenn, PW; Hinterseer, E; Schmölzer, J; Asslaber, D; Hainzl, S; Neureiter, D; Egle, A; Piñón-Hofbauer, J; Hartmann, TN; Greil, R; Kerschbaum, HH;
Leukemia. 2014; 28(4):954-958
Letters
Abstract/Keywords Web of Science PubMed Full Text
Kasabach-Merritt phenomenon in hepatic angiosarcoma.
Habringer, S; Boekstegers, A; Weiss, L; Hopfinger, G; Meissnitzer, T; Melchardt, T; Egle, A; Greil, R;
Br J Haematol. 2014; 167(5):716-718
Letters
Abstract/Keywords Web of Science PubMed Full Text
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R;
Ann Hematol. 2014; 93(3):459-462
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
AID induces intraclonal diversity and genomic damage in CD86(+) chronic lymphocytic leukemia cells.
Huemer, M; Rebhandl, S; Zaborsky, N; Gassner, FJ; Hainzl, S; Weiss, L; Hebenstreit, D; Greil, R; Geisberger, R;
Eur J Immunol. 2014; 44(12):3747-3757
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.
Melchardt, T; Magnes, T; Weiss, L; Grundbichler, M; Strasser, M; Hufnagl, C; Moik, M; Greil, R; Egle, A;
BMC COMPLEM ALTERN M. 2014; 14: 115
Case Reports
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Pleural decortication of a marginal zone lymphoma.
Melchardt, T; Weiss, L; Namberger, K; Pretsch, I; Hutter, J; Rettenbacher, L; Neureiter, D; Troch, M; Greil, R; Egle, A;
Ann Hematol. 2014; 93(7):1253-1254
Letters
Abstract/Keywords Web of Science PubMed Full Text
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M;
Br J Cancer. 2014; 111(1):55-60
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma.
Weiss, L; Melchardt, T; Habringer, S; Boekstegers, A; Hufnagl, C; Neureiter, D; Hopfinger, G; Greil, R; Egle, A;
Ann Oncol. 2014; 25(1):171-176
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

Malignant Lymphoblasts in T Cell Acute Lymphoblastic Leukemia Express High Levels of Kv1.3
Groessinger, E; Weiss, L; Chen, MY; Wulff, H; Greil, R; Kerschbaum, H
BIOPHYS J. 2014; 106(2): 551A-551A.
Abstracts (Journal)
Abstract/Keywords Web of Science
Clonal Evolution in Relapsed or Refractory Diffuse Large B Cell Lymphoma
Melchardt, T; Hufnagl, C; Weigert, O; Weinstock, DM; Kopp, N; Weiss, L; Neureiter, D; Trankenschuh, W; Hackl, H; Greil, R; Egle, A
BLOOD. 2014; 124(21):
Abstracts (Journal)
Abstract/Keywords Web of Science
Spliceosome Mediated RNA Trans-Splicing for Targeting Kappa(+) B-Cell Neoplasms
Weiss, L; Gruber, C; Koller, U; Pinon-Hofbauer, J; Hainzl, S; Hufnagl, C; Melchardt, T; Brachtl, G; Greil, R; Bauer, J; Egle, A
BLOOD. 2014; 124(21):
Abstracts (Journal)
Abstract/Keywords Web of Science

2013

Journal Articles

Mimicking the microenvironment in chronic lymphocytic leukaemia - where does the journey go?
Asslaber, D; Grössinger, EM; Girbl, T; Hofbauer, SW; Egle, A; Weiss, L; Greil, R; Hartmann, TN;
Br J Haematol. 2013; 160(5):711-714
Letters
Abstract/Keywords Web of Science PubMed Full Text
CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility.
Girbl, T; Hinterseer, E; Grössinger, EM; Asslaber, D; Oberascher, K; Weiss, L; Hauser-Kronberger, C; Neureiter, D; Kerschbaum, H; Naor, D; Alon, R; Greil, R; Hartmann, TN;
Cancer Res. 2013; 73(2): 561-570.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
[Autoimmune hemolysis accompanied by thrombopenia: consumption or myelodysplasia?].
Melchardt, T; Weiss, L; Egle, A;
Dtsch Med Wochenschr. 2013; 138(41): 2093-2095.
Case Reports
Abstract/Keywords Web of Science PubMed Full Text
What’s new in Hodgkin’s lymphoma: ASH 2012 and more
Melchardt, T; Weiss, L; Greil, R; Egle, A;
Magazine of European Medical Oncology. 2013; Volume 6, Issue 3: 193-196.
Reviews
Abstract/Keywords Full Text
Viral infections and their management in patients with chronic lymphocytic leukemia.
Melchardt, T; Weiss, L; Greil, R; Egle, A;
Leuk Lymphoma. 2013; 54(8):1602-1613
Reviews
Abstract/Keywords Web of Science PubMed Full Text
Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome.
Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Auberger, J; Hopfinger, G; Greil, R; Egle, A;
Oncol Lett. 2013; 6(6):1756-1758
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.
Namberger, K; Weiss, L; Krause, B; Melchardt, T; Greil, R;
Eur J Haematol. 2013; 90(4):349-350
Letters
Abstract/Keywords Web of Science PubMed Full Text
Circulating tumor DNA to monitor metastatic breast cancer.
Weiss, L; Hufnagl, C; Greil, R;
N Engl J Med. 2013; 369(1): 93
Letters
Abstract/Keywords Web of Science PubMed Full Text
ASH 2012 update chronic lymphocytic leukemia—the best is yet to come
Weiss, L; Melchardt, T; Greil, R; Hopfinger, G;
Magazine of European Medical Oncology. 2013; Volume 6, Issue 3: 177-180.
Reviews
Abstract/Keywords Full Text

Conference papers, proceedings, abstracts

Blockade of the Potassium Channel KCa3.1 inhibits proliferation in Chronic Lymphocytic Leukemia
Grossinger, EM; Weiss, L; Zierler, S; Hinterseer, E; Schmolzer, J; Asslaber, D; Hainzl, S; Egle, A; Pinon, JD; Hartmann, TN; Greil, R; Kerschbaum, HH
ONKOLOGIE. 2013; 36: 191-192.
Abstracts (Journal)
Abstract/Keywords Web of Science
Influence of Body Mass Index on survival in indolent and Mantle-cell Lymphomas: Analysis of the StiL1 trial
Weiss, L; Melchardt, T; Egle, A; Hopfinger, G; Greil, R; Barth, J; Rummel, M
ONKOLOGIE. 2013; 36: 31-32.
Abstracts (Journal)
Abstract/Keywords Web of Science

Book chapters

Diagnostik und Therapie von diffus großzelligen Lymphomen (DLBCL)
Egle, A; Melchardt, T; Weiss, L;
In: Hopfinger, G; Greil, R (Hrsg.) editors(s). Aktuelle Diagnostik und Therapieoptionen bei aggressiven Lymphomen.. Bremen, London, Boston: UniMed Verlag; p. 26-35. (ISBN: 978-3-8374-1407-3)
Abstract/Keywords

Newspaper/magazine articles

Lenalidomide/Rituximab Maintenance After Induction With Fludarabine/Rituximab In Combination With Escalating Doses Of Lenalidomide In Previously Untreated Chronic Lymphocytic Leukemia (CLL): The Revlirit CLL5 AGMT Phase I/II Study, Final Results
Egle, A; Steurer, M; Gassner, FJ; Geisberger, R; Melchardt, T; Pleyer, L; Weiss, L; Fridrik, MA; Thaler, J; Lang, A; Greil, R;
Blood (ASH Annual Meeting Abstracts). 2013. #4164:
Abstract/Keywords Full Text

2012

Conference papers, proceedings, abstracts

Feasibility of anthracycline based treatment in unselected elderly DLBCL patients
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Hopfinger, G; Greil, R; Egle, A
ONKOLOGIE. 2012; 35: 86-87.
Abstracts (Journal)
Abstract/Keywords Web of Science
Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient
Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Morre, P; Boekstegers, A; Hopfinger, G; Greil, R; Egle, A
BLOOD. 2012; 120(21):
Abstracts (Journal)
Abstract/Keywords Web of Science
Complications of 5-azacytidine: Three cases of severe colitis in a single center cohort
Melchardt, T; Weiss, L; Pleyer, L; Steinkirchner, S; Greil, R; Egle, A
ONKOLOGIE. 2012; 35: 149-149.
Abstracts (Journal)
Abstract/Keywords Web of Science

Newspaper/magazine articles

KCa3.1 Blockers Inhibit Cell Proliferation in Chronic Lymphocytic Leukemia
Groessinger, EM; Weiss, L; Hinterseer, E; Schmoelzer, J; Oberascher, K; Asslaber, A; Egle, A; Hartmann, TN; Greil, R; Kerschbaum, HH
Blood (ASH Annual Meeting Abstracts) 2012. 2012. #3887:
Abstract/Keywords Full Text

2011

Journal Articles

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner, FJ; Weiss, L; Geisberger, R; Hofbauer, JP; Egle, A; Hartmann, TN; Greil, R; Tinhofer, I;
Cancer Immunol Immunother. 2011; 60(1):7-85
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Regulatory T cells predict the time to initial treatment in early stage chronic lymphocytic leukemia.
Weiss, L; Melchardt, T; Egle, A; Grabmer, C; Greil, R; Tinhofer, I;
Cancer. 2011; 117(10):2163-2169
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Complete remission of Waldenström macroglobulinemia with azacitidine and rituximab.
Weiss, L; Melchardt, T; Neureiter, D; Kemmerling, R; Moshir, S; Pleyer, L; Greil, R; Egle, A;
J CLIN ONCOL. 2011; 29(24): e696-e698.
Case Reports
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results
Egle, A; Steurer, M; Gassner, F; Geisberger, R; Melchardt, T; Weiss, L; Fridrik, MA; Thaler, J; Lang, A; Greil, R
BLOOD. 2011; 118(21): 135-136.
Abstracts (Journal)
Abstract/Keywords Web of Science
CD44-hyaluronan interactions in the pathophysiology of chronic lymphocytic leukemia - regulation by cell activation
Girbl, T; Asslaber, D; Brachtl, G; Denk, U; Weiss, L; Naor, D; Greil, R; Hartmann, TN
ONKOLOGIE. 2011; 34: 140-140.
Abstracts (Journal)
Abstract/Keywords Web of Science

2010

Journal Articles

An uncommon cause of anaemia: Sheehan"s syndrome.
Melchardt, T; Namberger, K; Weiss, L; Egle, A; Faber, V; Greil, R;
WIEN KLIN WOCHENSCHR. 2010; 122(23-24): 717-719.
Case Reports
Abstract/Keywords Web of Science PubMed Full Text
Short review – Management of Immune Thrombocytopenia in adults
Weiss, L; Greil, R
Magazine of European Medical Oncology. 2010; Volume 3, Issue 2: 69-72.
Reviews
Abstract/Keywords Full Text

Conference papers, proceedings, abstracts

Final Analysis of Induction Treatment with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab In Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos AGMT CLL4/Roche ML18434 Study
Egle, A; Weiss, L; Melchardt, T; Gunsilius, E; Petzer, AL; Fridrik, M; Lang, A; Krieger, O; Thaler, J; Greil, R
BLOOD. 2010; 116(21): 593-594.
Abstracts (Journal)
Abstract/Keywords Web of Science

Book chapters

Rare Clonal Myeloid Diseases
Melchardt, T; Weiss, L; Pleyer, L; Neureiter, D; Faber, V; Greil, R;
In: Greil, R; Pleyer, L; Faber, V; Neureiter, D (Eds.) editors(s). Chronic Myeloid Neoplasias and Clonal Overlap Syndromes. Springer; (ISBN: 978-3-211-79891-1)
Abstract/Keywords Full Text

Newspaper/magazine articles

Short review – Management of Immune Thrombocytopenia in adults
Weiss, L; Greil, R
memo - Magazine of European Medical Oncology (2010) . 2010.
Abstract/Keywords

2009

Journal Articles

Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer, I; Weiss, L; Gassner, F; Rubenzer, G; Holler, C; Greil, R;
J Immunother. 2009; 32(3):302-309
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

The Inverse Correlation of Regulatory T Cells and Time to Initial Treatment in Chronic Lymphocytic B-Cell Leukemia
Weiss, L; Melchardt, T; Grabmer, C; Egle, A; Tinhofer, I; Greil, R
BLOOD. 2009; 114(22): 510-510.
Abstracts (Journal)
Abstract/Keywords Web of Science

2008

Conference papers, proceedings, abstracts

Minimal Residual Disease (MRD) and T/NK Cell Dynamics during Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab in Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): Riskfactor Stratification in the Chairos Study.
Egle, A; Weiss, L; Gassner, F; Russ, G; Pleyer, L; Gunsilius, E; Tinhofer, I; Thaler, J; Petzer, AL; Greil, R
BLOOD. 2008; 112(11): 1089-1089.
Abstracts (Journal)
Abstract/Keywords Web of Science

2007

Conference papers, proceedings, abstracts

Planned first efficacy and safety analysis of de-intensified induction with fludarabine, cyclophosphamide plus rituximab (FCR) followed by fludarabine plus rituximab (FR) and remission maintenance therapy with rituximab in previously untreated B-chronic lymphocytic leukemia (B-CLL): The chairos study
Egle, A; Weiss, L; Russ, G; Thoedtmann, R; Pleyer, L; Gastl, G; Thaler, J; Petzer, A; Tinhofer, I; Greil, R
BLOOD. 2007; 110(11): 609A-609A.
Abstracts (Journal)
Abstract/Keywords Web of Science